June 5, 2007 - Metcalf brings extensive manufacturing knowledge and an executive management background to the company. “They and our new corporate investors share our confidence that AMI’s Electroactive Polymer Artificial Muscle (EPAM) technology and products will introduce a revolutionary change in the $50B global actuator market. EPAM technology was developed at SRI over a 12-year period.